Malaria News and Research

Latest Malaria News and Research

Vaxonco initiates Phase I clinical trial of novel DNA-based polyepitope vaccine against malaria

Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.

23 Sep 2010

World leaders address country ownership, accountability, women at MDG summit

At the U.N. Summit on the Millennium Development Goals (MDGs) on Tuesday African leaders said "they could do more to meet U.N. goals to slash extreme poverty and urged stronger leadership among developing countries to tackle hunger and disease and attract investment," Reuters reports in an article that examines the leaders' call for African nations to take greater ownership over their development.

23 Sep 2010

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

"The U.N. estimates that diarrheal diseases kill 1.8 million people every year. … So you might take it as good news that American company Ventria Bioscience says it has hit on an improvement to existing rehydration therapies, which could mean another tool in the fight against diarrhea," according to a Wall Street Journal editorial examining the delays the company has experienced since it first sought to have its product approved by the FDA back in 2004, even "[a]fter a panel of food, medicine, immunology, child nutrition and health experts had declared its product safe."

23 Sep 2010

Islamic Relief USA provides $20 million medical aid to Pakistan

Islamic Relief USA (IR USA), a non-profit relief and development organization based in metro-D.C., announced today that it has delivered a $20 million aid shipment of medicine to Pakistan.

22 Sep 2010

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

22 Sep 2010

Secretary-General opens U.N. summit on MDGS with appeal for world leaders to maintain target commitments

On the first of the three-day U.N. Summit on the Millennium Development Goals (MDGs), U.N. Secretary-General Ban Ki-moon on Monday appealed "to the assembled presidents, prime ministers and kings to use their power to meet U.N. goals to help the world's poorest by 2015," the Associated Press reports.

22 Sep 2010

International activists ask: 'Will MDG summit fail HIV-positive people?'

A group of Russian AIDS activists are charging that the Russian Ministry of Health is denying that there are drug stock-outs that prevent patients from starting or continuing treatment. "In this situation, people with HIV face a choice: to die quietly at home or try to attract the attention of the government and the media," said Alexey Yaskovich, a Russian activist from Novgorod. "Therefore, activists will continue to go to the streets of Moscow and hold public events dedicated to saving their lives."

21 Sep 2010

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.

21 Sep 2010

U.N. MDG summit begins; UNAIDS data shows 22 African countries see drop in new HIV infections

"Ten years after world leaders set the most ambitious goals ever to tackle global poverty, they are meeting again to try to spur action to meet the targets by the 2015 deadline - which the U.N. says will be difficult, if not impossible, in some cases," the Associated Press reports. More than 140 world leaders are scheduled to participate in the three-day U.N. Summit on the Millennium Development Goals (MDGs), which kicks off Monday.

21 Sep 2010

Opinions: MDGs

"The overarching and noble goal [of this week's Millennium Development Goal (MDG) summit in New York] is reducing global poverty. But the most compelling and achievable objectives - huge reductions in maternal and child mortality worldwide - will be severely undermined if the Obama administration either directly or covertly integrates abortion into the final outcome document," Rep. Chris Smith (R-N.J.) writes in a Washington Post opinion piece.

21 Sep 2010

Biomagnetics signs merger agreement with Zhuhai Energy Science and Technology

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, recently announced its management team was flying to China to close its merger with Zhuhai Energy Science and Technology. Biomagnetics Diagnostics is pleased today to announce the signing of the formal merger agreement. All necessary governmental approvals are expected to be completed mid-week.

20 Sep 2010

Global child mortality declines by one-third since 1990, U.N. report says

The number of children who die before age 5 has declined by one-third since 1990, Reuters reports.

18 Sep 2010

Global Fund head repeats appeal for emerging countries to invest more in fight against AIDS, TB, malaria

Global Fund to Fight AIDS, Tuberculosis and Malaria Director Michel Kazatchkine on Thursday repeated his appeal for emerging countries to scale up their contributions to fight the three major diseases, Agence France-Presse reports.

18 Sep 2010

Opinions: Bachelet appointment; Sanitation MDG; Women's education; Smallholder farms

The appointment of former Chilean President Michelle Bachelet to head U.N. Women is an "excellent choice" that "adds stature and star power to the agenda for gender equality," according to a Los Angeles Times editorial.

18 Sep 2010

Researchers to conduct gene analysis for ankylosing spondylitis

A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).

16 Sep 2010

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today presented promising clinical data for CMX001 in a late-breaker poster session at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.

16 Sep 2010

Report: Prevention efforts averted almost 750,000 child Malaria deaths over 10 years

Malaria prevention efforts - such as the use of bed nets, indoor insecticide spraying and the use of drugs to prevent the disease - have prevented the deaths of almost 750,000 children in 34 African countries over the past 10 years, according to a report.

16 Sep 2010

ABCB4 gene causes bad cholesterol to accumulate in blood: Research

Scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio have found a gene that causes high levels of bad cholesterol to accumulate in the blood as a result of a high-cholesterol diet.

16 Sep 2010

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.

15 Sep 2010

Opinions: Global nursing; U.S. funding of Global Fund; Global demands for water; Food security

"Almost every nation, regardless of its wealth and resources, faces a continuing shortage of nurses and an acute lack of nursing faculty available to educate more nurses. This dearth of practicing nurses and nurse educators is particularly critical in countries like Haiti and other developing high-risk, low-resourced nations," Martha Hill, dean of Johns Hopkins School of Nursing, writes in a Baltimore Sun opinion piece encouraging the expansion of global nursing.

15 Sep 2010

Malaria News and Research

Latest Malaria News and Research

Vaxonco initiates Phase I clinical trial of novel DNA-based polyepitope vaccine against malaria

World leaders address country ownership, accountability, women at MDG summit

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

Islamic Relief USA provides $20 million medical aid to Pakistan

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Secretary-General opens U.N. summit on MDGS with appeal for world leaders to maintain target commitments

International activists ask: 'Will MDG summit fail HIV-positive people?'

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

U.N. MDG summit begins; UNAIDS data shows 22 African countries see drop in new HIV infections

Opinions: MDGs

Biomagnetics signs merger agreement with Zhuhai Energy Science and Technology

Global child mortality declines by one-third since 1990, U.N. report says

Global Fund head repeats appeal for emerging countries to invest more in fight against AIDS, TB, malaria

Opinions: Bachelet appointment; Sanitation MDG; Women's education; Smallholder farms

Researchers to conduct gene analysis for ankylosing spondylitis

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Report: Prevention efforts averted almost 750,000 child Malaria deaths over 10 years

ABCB4 gene causes bad cholesterol to accumulate in blood: Research

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Opinions: Global nursing; U.S. funding of Global Fund; Global demands for water; Food security

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in